AEON Biopharma Balance Sheet
AEON Biopharma's total assets for Q4 2025 were $5.56M, a decrease of -36.34% from the previous quarter. AEON total liabilities were $60.59M for the fiscal quarter, a 111.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.